| abstract |
Provided is a method for stabilizing in vitro and in vivo by fusing or binding a therapeutic protein such as interferon α to albumin or a fragment or variant of albumin. Therapeutic proteins (including but not limited to polypeptides, antibodies, peptides, or fragments or variants thereof) fused to albumin or albumin fragments or variants and dissolved states (solutions) A therapeutic protein fused to albumin or an albumin fragment or variant, and a nucleic acid molecule encoding the albumin fusion protein, a vector containing the nucleic acid, which exhibits a long shelf life and / or long-term therapeutic activity , A host cell transformed with the nucleic acid vector, a pharmaceutical composition containing an albumin fusion protein, and a method for treating, preventing or ameliorating a disease, disorder or condition using the albumin fusion protein of the present invention. [Selection figure] None |